Phase 2 Chronic Kidney Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You carry a specific genetic variation called APOL1 high risk genotype (either G1/G1, G2/G2, or G1/G2) — this is determined by a genetic test
- You have chronic kidney disease with a lasting higher-than-normal level of protein in your urine (confirm with trial site)
Who may not be able to join:
- You have had an organ transplant or bone marrow transplant
- You have been diagnosed with cancer in the past 2 years (though some exceptions may apply for certain treated skin cancers, an early stage of cervical cancer, or an early stage of prostate cancer — confirm with trial site)
- You have a medical condition or have had surgery (such as weight loss surgery) that could affect how your body absorbs medication
- You have Type 1 diabetes
- You are currently pregnant or breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Medical Director, Maze Therapeutics
Phone: 650-850-5075
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Safety and tolerability as assessed by incidence of adverse events (AEs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.